Top Biotechnology companies in Denmark by EBITDA

This ranking features the top 17 Biotechnology companies in Denmark ranked by EBITDA, totaling a EBITDA of USD 20.81 B, for July 26, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Denmark has the highest EBITDA ?

The Biotechnology company in Denmark with the highest EBITDA is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 19.06 B.

Which Biotechnology company in Denmark has the lowest EBITDA ?

The Biotechnology company in Denmark with the lowest EBITDA is 2cureX AB (publ) (Stockholm Stock Exchange: 2CUREX.ST) at None.

What are the top 10 Biotechnology companies in Denmark by EBITDA ?

The top 10 Biotechnology companies in Denmark by EBITDA are Novo Nordisk A/S, Genmab A/S, H. Lundbeck A/S, Bavarian Nordic A/S, ALK-Abelló A/S, ChemoMetec A/S, Saniona AB (publ), Initiator Pharma A/S, ViroGates A/S and Gubra A/S.

What are the bottom 10 Biotechnology companies in Denmark by EBITDA ?

The bottom 10 Biotechnology companies in Denmark by EBITDA are 2cureX AB (publ), Ascendis Pharma A/S, Zealand Pharma A/S, IO Biotech, Inc., Evaxion Biotech A/S, BioPorto A/S, FluoGuide A/S, Gubra A/S, ViroGates A/S and Initiator Pharma A/S.